Memory impairment associated with neurometabolic abnormalities of the hippocampus in patients with non-neuropsychiatric systemic lupus erythematosus

Lupus

Volumn 20, Issue 6, 2011, Pages 598-606

  Kozora, E ^a,b   Brown, M S ^b   Filley, C M ^b,c   Zhang, L ^a   Miller, D E ^b   West, S G ^b   Pelzman, J ^a   Arciniegas, D B ^b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

hippocampal volume; lupus; memory function; neurometabolites

Indexed keywords

CREATINE; GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; METABOLIC DISORDER; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; VERBAL MEMORY; VISUAL MEMORY;

ADULT; ASPARTIC ACID; CASE-CONTROL STUDIES; CREATINE; FEMALE; GLUTAMIC ACID; HIPPOCAMPUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES;

EID: 79956161732     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203310392425     Document Type: Article

References (52)

1. Kozora E Textbook of Clinical Neuropsychology. Morgan JE Ricker JH, ed. New York: Taylor and Francis ; 2008: 636-649.
2. Kozora E, Ellison MC, West S. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery. Arthritis Rheum. 2006 ; 55: 628-635 (Pubitemid 44289884)
3. Denburg SD, Carbotte RM, Denburg JA. Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol. 1987 ; 9: 323-339 (Pubitemid 17094802)
4. Kozora E, Thompson LL, West SG, Kotzin BL. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum. 1996 ; 39: 2035-2045 (Pubitemid 27009072)
5. Kozora E, Ellison MC, West S. Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus. Arthritis Rheum. 2004 ; 51: 810-818 (Pubitemid 39372041)
6. Monastero R, Bettini P, Del Zotto E, et al. Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. J Neurol Sci. 2001 ; 184: 33-39 (Pubitemid 32166723)
7. Kozora E, Hanly JG, Lapteva L, Filley CM. Cognitive dysfunction in systemic lupus erythematosus: Past, present, and future. Arthritis Rheum. 2008 ; 58: 3286-3298
8. Sakic B, Szechtman H, Denburg JA, Gorny G, Kolb B, Whishaw IQ. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice. J Neuroimmunol. 1998 ; 87: 162-170 (Pubitemid 28319857)
9. Tomita M, Holman BJ, Santoro TJ. Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus. Neurosci Lett. 2001 ; 302: 129-132 (Pubitemid 32274226)
10. Vogelweid CM, Wright DC, Johnson JC, Hewett JE, Walker SE. Evaluation of memory, learning ability, and clinical neurologic function in pathogen-free mice with systemic lupus erythematosus. Arthritis Rheum. 1994 ; 37: 889-897 (Pubitemid 24184541)
11. Walker SE, Wright DC, O'Sullivan FX, Johnson GC, Besch-Williford CL, Vogelweid CM. Memory, learning ability, and neuropathologic status of mice with systemic lupus erythematosus. Ann N Y Acad Sci. 1997 ; 823: 107-115 (Pubitemid 27424891)
12. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med. 2001 ; 7: 1189-1193 (Pubitemid 33063773)
13. Grunwald T, Beck H, Lehnertz K, et al. Evidence relating human verbal memory to hippocampal N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A. 1999 ; 96: 12085-12089 (Pubitemid 29502862)
14. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994 ; 330: 613-622
15. Kotzin BL, Kozora E. Anti-DNA meets NMDA in neuropsychiatric lupus. Nat Med. 2001 ; 7: 1175-1176 (Pubitemid 33063760)
16. Deweer B, Lehericy S, Pillon B, et al. Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. J Neurol Neurosurg Psychiatry. 1995 ; 58: 590-597
17. O'Brien JT, Desmond P, Ames D, Schweitzer I, Tuckwell V, Tress B. The differentiation of depression from dementia by temporal lobe magnetic resonance imaging. Psychol Med. 1994 ; 24: 633-640 (Pubitemid 24265746)
18. Trenerry MR, Jack CR, Ivnik RJ, et al. MRI hippocampal volumes and memory function before and after temporal lobectomy. Neurology. 1993 ; 43: 1800-1805 (Pubitemid 23307958)
19. Bigler ED, Snyder JL. Neuropsychological outcome in quantitative neuroimaging in mild head injury. Arch Clin Neuropsychol. 1995 ; 10: 159-174
20. Kozora E, Arciniegas DB, Filley CM, et al. Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data. Cogn Behav Neurol. 2005 ; 18: 159-162 (Pubitemid 41407452)
21. Appenzeller S, Carnevalle AD, Li LM, Costallat LT, Cendes F. Hippocampal atrophy in systemic lupus erythematosus. Ann Rheum Dis. 2006 ; 65: 1585-1589 (Pubitemid 44799669)
22. Catani M, Cherubini A, Howard R, et al. (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging. Neuroreport. 2001 ; 12: 2315-2317 (Pubitemid 32682179)
23. Kantarci K, Jack CR, Xu YC, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology. 2000 ; 55: 210-217 (Pubitemid 30604620)
24. Li LM, Cendes F, Antel SB, et al. Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy. Ann Neurol. 2000 ; 47: 195-200 (Pubitemid 30078566)
25. Otsuka H, Harada M, Mori K, Hisaoka S, Nishitani H. Brain metabolites in the hippocampus-amygdala region and cerebellum in autism: an 1H-MR spectroscopy study. Neuroradiology. 1999 ; 41: 517-519 (Pubitemid 29348670)
26. Schuff N, Amend DL, Knowlton R, Norman D, Fein G, Weiner MW. Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging. Neurobiol Aging. 1999 ; 20: 279-285 (Pubitemid 29525413)
27. Vermathen P, Laxer KD, Matson GB, Weiner MW. Hippocampal structures: anteroposterior N-acetylaspartate differences in patients with epilepsy and control subjects as shown with proton MR spectroscopic imaging. Radiology. 2000 ; 214: 403-410 (Pubitemid 30077695)
28. Dixon RM, Bradley KM, Budge MM, Styles P, Smith AD. Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain. 2002 ; 125: 2332-2341
29. Chinn RJ, Wilkinson ID, Hall-Craggs MA, et al. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 36-46 (Pubitemid 27044034)
30. Brooks WM, Jung RE, Ford CC, Greinel EJ, Sibbitt WL. Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus. J Rheumatol. 1999 ; 26: 81-85 (Pubitemid 29051400)
31. Sabet A, Sibbitt WL, Stidley CA, Danska J, Brooks WM. Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus. Stroke. 1998 ; 29: 2254-2260 (Pubitemid 28511941)
32. Griffin JL, Bollard M, Nicholson JK, Bhakoo K. Spectral profiles of cultured neuronal and glial cells derived from HRMAS (1)H NMR spectroscopy. NMR Biomed. 2002 ; 15: 375-384
33. Wolfson M, Bersudsky Y, Hertz E, Berkin V, Zinger E, Hertz L. A model of inositol compartmentation in astrocytes based upon efflux kinetics and slow inositol depletion after uptake inhibition. Neurochem Res. 2000 ; 25: 977-982 (Pubitemid 30636997)
34. Auld DS, Robitaille R. Glial cells and neurotransmission: an inclusive view of synaptic function. Neuron. 2003 ; 40: 389-400 (Pubitemid 37244103)
35. Glanville NT, Byers DM, Cook HW, Spence MW, Palmer FB. Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. Biochim Biophys Acta. 1989 ; 1004: 169-179 (Pubitemid 19193177)
36. Ross BD, Bluml S, Cowan R, Danielsen E, Farrow N, Tan J. In vivo MR spectroscopy of human dementia. Neuroimaging Clin N Am. 1998 ; 8: 809-822 (Pubitemid 28532518)
37. Kam K, Nicoll R. Excitatory synaptic transmission persists independently of the glutamate-glutamine cycle. J Neurosci. 2007 ; 27: 9192-9200 (Pubitemid 47312054)
38. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
39. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
40. Sipe JC, Knobler RL, Barheny SL, Rice GP, Panitch HS, Oldstone MB. A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology. 1984 ; 34: 1368-1372 (Pubitemid 14047252)
41. Smith SM. Fast robust automated brain extraction. Human Brain Mapping. 2002 ; 17: 143-155 (Pubitemid 35253488)
42. Arciniegas DB, Topkoff JL, Rojas DC, et al. Reduced hippocampal volume in association with P50 nonsuppression following traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2001 ; 13: 213-221 (Pubitemid 32499673)
43. Beresford T, Arciniegas D, Rojas D, et al. Hippocampal to pituitary volume ratio: a specific measure of reciprocal neuroendocrine alterations in alcohol dependence. J Stud Alcohol. 1999 ; 60: 586-588 (Pubitemid 29382351)
44. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993 ; 30: 672-679 (Pubitemid 23360802)
45. Delis D, Kramer J, Kaplan E, Ober B California Verbal Learning Test-Second Edition. San Antonio, TX: The Psychological Corporation ; 2000 :
46. Corwin J, Bylsma FW. Translations of exerpts from Andre Rey's psychological examination of traumatic encephalopathy and P.A. Osterrieth's "The Complex Figure Copy Test". Clin Neuropsychol. 1993 ; 7: 3-15
47. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982 ; 21: 1-16 (Pubitemid 12093480)
48. Neale JH, Olszewski RT, Gehl LM, Wroblewska B, Bzdega T. The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia. Trends Pharmacol Sci. 2005 ; 26: 477-484 (Pubitemid 41207880)
49. Kowal C, DeGiorgio LA, Nakaoka T, Diamond B, Volpe B. Cognition and immunity: Antibody impairs memory. Immunity. 2004 ; 21: 179-188 (Pubitemid 39094048)
50. Kozora E, West SG, Maier SF, et al. Antibodies against N-Methyl-D-Aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. J Neurol Sci. 2010 ; 295: 87-91
51. Kozora E, Maier S, Zhang L, et al. Cytokines, antiphospholipids and cognition in nonNPSLE. Brain Behav Immun. 2008 ; 22: 11a - 11a
52. Filley CM, Kozora E, Brown MS, et al. White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus. Cogn Behav Neurol. 2009 ; 22: 38-44